- Home
- About
- Find staff
- Maria Larsson
Maria Larsson
-
Evaluation of novel radiation protection devices during radiologically guided
interventions
Maria Larsson, Pernilla Jonasson, Petra S. Apell, Peter P. Kearney, Charlotta Lundh
CVIR ENDOVASCULAR - 2024 -
EVALUATION OF RADIATION DOSES USING CONE BEAM COMPUTED TOMOGRAPHY IN ENDOVASCULAR AORTIC REPAIR AND SCOLIOSIS
PROCEDURES
Louise Strandberg, P. Jonasson, Maria Larsson
Radiation Protection Dosimetry - 2021 -
Implementation of a novel return-to-work approach for persons with affective disorders in a traditional vocational rehabilitation context: a case
study
S. Johanson, U. Markstrom, Maria Larsson, U. Bejerholm
International Journal of Mental Health Systems - 2020 -
Gothenburg Very Early Supported Discharge study (GOTVED): a randomised controlled trial investigating anxiety and overall disability in the first year after
stroke.
Lena Rafsten, Anna Danielsson, Åsa Nordin, Ann Björkdahl, Åsa Lundgren Nilsson, Maria Larsson, Katharina Stibrant Sunnerhagen
BMC neurology - 2019 -
Renal function affects absorbed dose to the kidneys and haematological toxicity during (177)Lu-DOTATATE
treatment.
Johanna Svensson, Gertrud Berg, Bo Wängberg, Maria Larsson, Eva Forssell-Aronsson, Peter Bernhardt
European journal of nuclear medicine and molecular imaging - 2015 -
Potential Biomarkers for Radiation-Induced Renal Toxicity following 177Lu-Octreotate Administration in
Mice.
Emil Schüler, Maria Larsson, Toshima Z Parris, Martin E Johansson, Khalil Helou, Eva Forssell-Aronsson
PloS one - 2015 -
Optimization of 177Lu-octreotate treatment of neuroendocrine
tumours
Eva Forssell-Aronsson, Johan Spetz, Britta Langen, Johanna Dalmo, Maria Larsson, Mikael Montelius, Nils Rudqvist, Toshima Z Parris, Yvonne Arvidsson, Maria Ljungberg, Khalil Helou, Ola Nilsson, Bo Wängberg
3rd Swedish Cancer Research Meeting, Stockholm, Sweden, September 2-3, 2014 - 2014 -
Therapy with 177Lu-octreotate - pharmacokinetics, dosimetry and kidney
toxicity
Maria Larsson
2014 -
Kidney toxicity in mice treated with
177Lu-octreotate
Maria Larsson, Emil Schüler, Toshima Z Parris, Nils Rudqvist, Khalil Helou, Håkan Ahlman, Eva Forssell-Aronsson
25th Annual Congress on European Association of Nuclear Medicine, Milano, Italy, October 27-31, 2012 . (European Journal of Nuclear Medicine and Molecular Imaging) - 2012 -
Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar
scintigraphy.
Maria Larsson, Peter Bernhardt, Johanna Svensson, Bo Wängberg, Håkan Ahlman, Eva Forssell-Aronsson
EJNMMI research - 2012 -
Absorbed dose to the kidneys after treatment with
177Lu-octreotate
Maria Larsson, Peter Bernhardt, Eva Forssell-Aronsson
European Journal of Nuclear Medicine & Molecular Imaging - 2011 -
Absorbed dose to the kidneys after treatment with
177Lu-octreotate
Maria Larsson, Peter Bernhardt, Eva Forssell-Aronsson
European Association of Nuclear Medicine Congress. Birmingham - 2011 -
[(177)Lu-DOTA(0)-Tyr (3)]-Octreotate Treatment in Patients with Disseminated Gastroenteropancreatic Neuroendocrine Tumors: The Value of Measuring Absorbed Dose to the
Kidney.
Christina Swärd, Peter Bernhardt, Håkan Ahlman, Bo Wängberg, Eva Forssell-Aronsson, Maria Larsson, Johanna Svensson, Rauni Rossi-Norrlund, Lars Kölby
World journal of surgery - 2010 -
Dosimetric estimation of kidney dose after patient treatments with 177Lu- DOTA, Tyr3-octreotate on neuroendocrine somatostatin-Receptor-Expressing
tumour
Maria Larsson
workshop: Quantitative imaging and dosimetry in Nuclear Medicine - 2008